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ABSTRACT
Objectives:Many cross-sectional surveys have reported the prevalence of uninvestigated
dyspepsia, but there has been no recent systematic review of data from all studies to
determine its global prevalence and risk factors.
Design:MEDLINE, EMBASE, and EMBASE Classic were searched (until January 2014) to
identify population-based studies that reported the prevalence of uninvestigated dyspepsia in
DGXOWV\HDUVROGG\VSHSVLDZDVGHILQHGXVLQJV\PSWRPEDVHGFULWHULDRU
questionnaires. The prevalence of dyspepsia was extracted for all studies, and according to
the criteria used to define it. Pooled prevalence, according to study location and certain other
characteristics, odds ratios (OR), and 95% confidence intervals (CIs) were calculated.
Results: Of the 306 citations evaluated, 103 reported the prevalence of uninvestigated
dyspepsia in 100 separate study populations, containing 312 415 subjects. Overall pooled
prevalence in all studies was 20.8% (95% CI 17.8% to 23.9%). The prevalence varied
according to country (from 1.8% to 57.0%) and criteria used to define dyspepsia. The greatest
prevalence values were found when a broad definition of dyspepsia (29.5%; 95% CI 25.3%-
33.8%) or upper abdominal or epigastric pain or discomfort (20.4%; 95% CI 16.3%-24.8%)
were used. The prevalence was higher in women (OR 1.24; 95% CI 1.13 to 1.36), smokers
(OR 1.25; 95% CI 1.12 to 1.40), NSAID users (OR 1.59; 95% CI 1.27-1.99), and H. pylori-
positive individuals (OR 1.18; 95% CI 1.04-1.33).
Conclusion: The overall pooled prevalence of uninvestigated dyspepsia was 21%, but varied
among countries and according to the criteria used to define its presence. Prevalence is
significantly higher in women, smokers, NSAID users, and H. pylori-positive individuals,
although these associations were modest.
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What is already known about this subject?
Uninvestigated dyspepsia is common in the community.
Proposed risk factors include female gender, smoking, non-steroidal inflammatory drug use
and Helicobacter pylori infection.
There has been no systematic synthesis of data concerning the prevalence of uninvestigated
dyspepsia worldwide.
What are the new findings?
Up to one in five individuals report dyspepsia in the community.
Prevalence varies remarkably worldwide, and this is not explained by differing criteria used
to define dyspepsia.
Female gender, smoking, non-steroidal inflammatory drug use and Helicobacter pylori were
only modestly associated with presence of uninvestigated dyspepsia in the community.
How might it impact on clinical practice in the near future?
These data provide a robust analysis of the prevalence of uninvestigated dyspepsia, allowing
for health service provision planning.
They could be plotted against other prevalence data, at individual country level, in order to
determine novel risk factors for the condition.
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INTRODUCTION
Dyspepsia is a symptom complex, rather than a diagnosis. Definitions of dyspepsia
have evolved over the years, from one that includes any symptom felt to be referable to the
upper gastrointestinal (GI) tract, [1] to the Rome criteria, [2-5] which have deliberately
attempted to exclude heartburn and regurgitation from the definition, as these are felt to be
indicative of underlying gastro-oesophageal reflux disease. The situation is further
complicated by the fact that the classification of dyspepsia depends on whether upper GI
endoscopy has been performed and, if so, whether relevant pathology was detected.
Individuals who have not undergone investigation are said to have uninvestigated dyspepsia.
Dyspeptic patients who undergo upper GI investigation and have pathological findings that
may be responsible for the symptoms, such as peptic ulcer, are classed as having organic
dyspepsia. Those without a detectable cause, who make up over three-quarters of individuals,
are labelled as having functional dyspepsia, while gastro-oesophageal malignancy remains
rare as a cause of dyspepsia. [6]
Although people with dyspepsia have a normal life expectancy, [7, 8] the impact on
quality of life is substantial. There have been several studies reporting a reduced quality of
life in patients with functional dyspepsia, compared with healthy controls or the general
population. [9-12] The direction of the association between reduced quality of life and
dyspepsia remains unclear, although in a 10-year follow-up of individuals from the
community, one of the strongest predictors of the development of new-onset dyspepsia was
poor quality of life at baseline. [13] Dyspepsia is associated with higher rates of absenteeism
from employment, lower productivity at work, missed leisure time, reduced activity around
the house, and greater medical and prescription medicine costs per year, [14,15] meaning that
the financial implications of dyspepsia for society as a whole are huge. [16]
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There have been numerous cross-sectional surveys conducted that report the
prevalence of dyspepsia in the community. [17-24] As the majority of these types of study do
not perform upper GI endoscopy, the cause of dyspepsia in those who report symptoms
remains unclear, and it is probably best to classify these individuals as having uninvestigated
dyspepsia. Despite the wealth of studies examining this issue, the prevalence of
uninvestigated dyspepsia according to geographical location has not been well-reported, and
no single study has synthesised data concerning potential risk factors for its presence.
Systematic analysis of studies that report these types of data is important to allow physicians
consulting with sufferers to provide more precise estimates of the prevalence of, as well as
risk factors for, the condition, and to identify areas where further research is needed. We have
therefore conducted a systematic review and meta-analysis of the prevalence of
uninvestigated dyspepsia in the global community to examine these issues.
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METHODS
Search Strategy and Study Selection
A literature search was performed using EMBASE CLASSIC and EMBASE (1947 to
January 2014), and MEDLINE (1948 to January 2014) to identify only cross-sectional
surveys published in full that reported the prevalence of dyspepsia in adults (aged 15 years
and over). Studies were required to recruit participants from the general population or
community. Any studies that reported the prevalence of dyspepsia in convenience samples,
such as university students, employees at an institution, or those attending screening clinic
health check-ups were not eligible for inclusion. In order to be eligible, studies also had to
recruit at least 50 participants, and define dyspepsia according to one or more of the
following: a broad definition in line with the 1988 Working Party report, including any
symptom referable to the upper GI tract (including heartburn or reflux), (1) upper abdominal
or epigastric pain or discomfort alone, the Rome I, (4) Rome II, (5) or Rome III criteria, (3)
or according to a questionnaire. These eligibility criteria, which were defined prospectively,
are provided in Box 1.
The medical literature was searched using the following terms: dyspepsia (both as a
medical subject heading (MeSH) and free text term), dyspep$, epigastric adj5 pain, satiety,
non-ulcer dyspepsia, functional dyspepsia, upper gastrointestinal symptom$, or upper
gastrointestinal adj5 symptom (as free text terms). These were combined using the set
operator AND with studies identified with the terms: prevalence, incidence, or frequency
(both as MeSH and free text terms), or proportion (as a free text term). There were no
language restrictions. The resulting abstracts were then screened for potential suitability, and
those that appeared relevant were retrieved and examined in more detail. A recursive search
was performed using the bibliographies of all obtained articles. Foreign language articles
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were translated, where required. Where there appeared to be multiple study reports from the
same group of subjects, we contacted study authors to clarify this issue. Eligibility
assessment was performed independently by two investigators, using pre-designed eligibility
forms. Any disagreements were resolved by consensus.
Data Extraction
Data were extracted independently by two investigators on to a Microsoft Excel
spreadsheet (XP professional edition; Microsoft, Redmond, WA, USA), again with any
discrepancies resolved by consensus. The following data were collected for each study:
year(s) conducted, country and geographical region, method of data collection (postal
questionnaire, interview-administered questionnaire, self-completed questionnaire, telephone
interview, face-to-face interview, web-based questionnaire), criteria used to define dyspepsia,
symptom duration used to define dyspepsia, number of subjects providing complete data,
mean age of subjects, proportion of male subjects, and the number of subjects with dyspepsia.
Where dyspepsia prevalence was reported according to more than one set of diagnostic
criteria in an individual study, the number of subjects with dyspepsia according to each
individual definition was extracted.
Data Synthesis and Statistical Analysis
The proportion of individuals with dyspepsia in each study was combined to give a
pooled prevalence of dyspepsia for all studies, according to the criteria used to define its
presence. Heterogeneity between studies was assessed using the I2 statistic with a cut off of
DQGWKHȤ2 test with a P value <0.10, [25] used to define a statistically significant degree
of heterogeneity. Subgroup analyses were conducted according to geographical region,
criteria used to define dyspepsia, symptom duration used to define presence of dyspepsia,
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gender, current smoking status, H. pylori status, and use of non-steroidal anti-inflammatory
drugs (NSAIDs), including aspirin, self-reported by the participants, in order to assess
whether this had any effect on the pooled prevalence of dyspepsia. Finally, the prevalence of
dyspepsia was compared according to gender, current smoking status, H. pylori status, and
self-reported use or non-use of NSAIDS, using an odds ratio (OR), with a 95% confidence
interval (CI). Given that the broader definition of dyspepsia, which includes any symptom
referable to the upper GI tract, is likely to be more relevant to clinical situations compared
with the Rome criteria, which are geared towards research into the treatment and
pathophysiology of functional dyspepsia, we performed further subgroup analyses restricted
to studies using only a broad definition of dyspepsia.
Data were pooled using a random effects model, [26] to give a more conservative
estimate of the prevalence of dyspepsia and the odds of dyspepsia in these various groups.
StatsDirect version 2.7.2 (StatsDirect Ltd, Sale, Cheshire, England) was used to generate
Forest plots of pooled prevalences and pooled ORs with 95% CIs. Evidence of publication
bias was assessed for, by applying Egger’s test to funnel plots of odds ratios, [27] where a
sufficient number of studies were available. [28]
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RESULTS
The search strategy identified 42 939 citations. From these we identified 307 that
appeared to be relevant to the study question. There were 103 articles that fulfilled the
eligibility criteria, representing 100 separate adult study populations, containing 312 415
subjects (Supplementary Figure 1). [13, 14, 17, 19, 21-24, 29-123] There were a further three
papers that reported data concerning prevalence of dyspepsia according to NSAID use,
gender, and / or H. pylori status from one of these 100 separate study populations that were
not published in the primary article arising from that study, [124-126] meaning that we
extracted data from 106 separate articles in total. Agreement between investigators for
assessment of study eligibility was excellent (kappa statistic = 0.90).
Detailed characteristics of all included studies are provided in Supplementary Table 1.
The prevalence of dyspepsia in the community, when data from all 99 separate studies were
pooled, was 20.8% (95% CI 17.8% to 23.9%). The lowest prevalence reported was 1.8% in
two studies, one of which was conducted in Canada and used the Rome II criteria, and the
other a Chinese study that used the Rome III criteria. The highest prevalence was 57.0%,
reported in a Japanese study that used upper abdominal or epigastric pain or discomfort to
define dyspepsia.
Global Prevalence of Dyspepsia
The majority of studies were conducted in Northern Europe or South-East Asia. There
were no studies conducted in South Asia, one conducted in Central America, and only a few
studies from South America, Africa, and the Middle East. The pooled prevalence of
dyspepsia according to geographical location of the study is provided in Table 1. There was
statistically significant heterogeneity between studies in all of these analyses. The lowest
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Table 1. Pooled Prevalence of Uninvestigated Dyspepsia According to Geographical Location.
Number of
studies
Number of
subjects
Pooled
prevalence
(%)
95% confidence
interval
I
2
P value
for I
2
All studies
North European studies
South East Asian studies
North American studies
Australasian studies
South European studies
Middle Eastern studies
South American studies
African studies
Central American studies
100
41
21
9
9
9
7
5
2
1
312 415
135 966
80 913
28 817
15 998
15 812
26 531
6427
1451
500
20.8
21.7
14.6
22.1
20.6
24.3
15.2
37.7
35.7
7.0
17.8 – 23.9
18.4 – 25.3
8.1 – 22.6
7.0 – 42.5
13.5 – 28.8
16.6 – 33.0
8.3 – 23.8
28.5 – 47.3
19.2 – 54.2
5.0 – 10.0
99.8%
99.7%
99.9%
99.9%
99.1%
99.3%
99.5%
97.8%
N/A*
N/A*
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
N/A*
N/A*
* N/A; not applicable, too few studies to assess heterogeneity
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prevalence of dyspepsia occurred in the Central American study (7.0%) and the highest in
South America (37.7%).
Prevalence of Dyspepsia According to Criteria Used to Define its Presence
The majority of studies used accepted diagnostic criteria to define the presence of
dyspepsia, with 15 using more than one set of criteria within the same population. In total, 38
studies used a broad definition of dyspepsia, 36 used upper abdominal or epigastric pain or
discomfort, 19 the Rome II criteria, 12 the Rome I criteria, and only seven the Rome III
criteria. There were another seven studies that used a symptom questionnaire to define
dyspepsia, and in four studies the authors stated that this was validated.
The pooled prevalence of dyspepsia according to the various criteria used to define its
presence is provided in Table 2. Prevalence was highest when a broad definition was used
(29.5%; 95% CI 25.3% to 33.8%), and lowest when the Rome III criteria were used (7.6%;
95% CI 4.6% to 11.3%). In the case of the Rome III criteria, the prevalence in individual
countries ranged from 2% to 11%. The prevalence according to a broad definition, when
upper abdominal or epigastric pain or discomfort, or the Rome II criteria were used to define
dyspepsia by country are shown in Figures 1, 2, and 3. The continued disparity in prevalence
of dyspepsia by country in these analyses suggests that the geographical variation was not
related solely to the diagnostic criteria used in each study.
Prevalence of Dyspepsia According to Duration of Symptoms
Seventy-two studies reported the duration of symptoms required to meet diagnostic
criteria for dyspepsia, with 36 using 12 months, 15 using 3 months, 11 using 6 months, four
using 1 month, three using 2 weeks, two using 1 week, and one using both 3 and 12 months.
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Table 2. Pooled Prevalence of Uninvestigated Dyspepsia According to Criteria Used to Define its Presence, Duration of Symptoms, and
Method Used to Collect Symptom Data.
Number of
studies
Number of
subjects
Pooled
prevalence
(%)
95% confidence
interval
I
2
P value
for I
2
All studies
Criteria used to define dyspepsia
Broad definition
Upper abdominal or epigastric pain or discomfort
Rome II
Rome I
Rome III
Questionnaire-defined
Duration of symptoms
1 week
2 weeks
100
38
36
19
12
7
7
2
3
312 415
106 975
109 120
46 683
23 545
50 675
11 434
13 925
6016
20.8
29.5
20.4
19.0
21.8
7.6
21.4
30.2
19.8
17.8 – 23.9
25.3 – 33.8
16.3 – 24.8
11.6 – 27.7
12.3 – 33.1
4.6 – 11.3
10.5 – 34.9
16.3 – 46.2
2.3 – 48.4
99.8%
99.6%
99.7%
99.8%
99.7%
99.5%
99.5%
N/A*
N/A*
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
N/A*
N/A*
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1 month
3 months
6 months
12 months
Method used to collect symptom data
Postal questionnaire
Interview-administered questionnaire
Self-completed questionnaire
Telephone interview
Internet-based questionnaire
Face-to-face interview
4
16
11
37
35
33
13
9
3
2
5658
72 934
32 769
51 671
105 123
88 733
45 937
30 047
46 201
666
35.5
19.8
28.2
23.3
22.7
22.1
21.6
22.4
9.5
41.7
14.5 – 59.9
12.0 – 28.9
20.1 – 37.1
19.3 – 27.6
17.4 – 28.5
17.6 – 26.9
11.6 – 33.6
10.2 – 37.7
6.7 – 12.7
33.1 – 50.5
99.7%
99.9%
99.6%
99.2%
99.8%
99.6%
99.9%
99.8%
N/A*
N/A*
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
< 0.001
N/A*
N/A*
* N/A; not applicable, too few studies to assess heterogeneity
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The prevalence of dyspepsia was highest in studies that used a 1-month timeframe (35.5%),
but was also higher in studies that used 6 months compared with those that used 12 months
(28.2% versus 23.3%, Table 2). The prevalence of dyspepsia in the community when data
from studies that required a symptom duration of 1 month or less, or studies that did not
report the duration of symptoms required, were excluded was 23.1% (95% CI 19.5% to
27.0%).
When only studies that used a broad definition of dyspepsia were considered the
results were as follows: 13 studies used a symptom duration of 1 year (prevalence = 26.3%;
95% CI 18.7% to 34.7%), six studies used a symptom duration of 3 months (prevalence =
26.0%; 95% CI 15.7% to 37.9%), six studies used a symptom duration of 6 months
(prevalence = 32.4%; 95% CI 24.3% to 41.1%), three studies used a symptom duration of 1
month (prevalence = 45.2%; 95% CI 36.8% to 53.8%), two studies used a symptom duration
of 1 week (prevalence = 30.2%; 95% CI 16.3% to 46.2%), and one study used a symptom
duration of 2 weeks (prevalence = 27.5%; 95% CI 25.4% to 29.6%).
Prevalence of Dyspepsia According to Method of Symptom Data Collection
There were four studies that did not report the exact method used to collect symptom
data, and a further two studies that used two separate methods within the population under
study that could not be separated. In the remaining studies, 34 used a postal questionnaire, 32
used a questionnaire administered face-to-face by an interviewer, 13 a self-completed
questionnaire, nine a questionnaire completed during a telephone interview, three studies an
internet-based questionnaire, two conducted a face-to-face interview, and one used both a
postal questionnaire and an interview-administered questionnaire at two separate time points.
Pooled prevalence of dyspepsia was highest in the two studies that conducted a face-to-face
interview (41.7%), and lowest in the three studies that used an internet-based questionnaire
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(9.5%). The prevalence of dyspepsia using all other methods was broadly comparable (Table
2).
When only studies that used a broad definition of dyspepsia were considered the
results were as follows: 13 studies used a postal questionnaire (prevalence = 27.5%; 95% CI
21.6% to 33.8%), 11 studies used an interview-administered questionnaire (prevalence =
30.4%; 95% CI 23.8% to 37.5%), eight studies used a self-completed questionnaire
(prevalence = 30.2%; 95% CI 19.6% to 42.0%), four studies used a telephone interview
(prevalence = 34.8%; 95% CI 20.4% to 50.9%), and two studies used a face-to-face interview
(prevalence = 41.7%; 95% CI 33.1% to 50.5%).
Prevalence of Dyspepsia According to Gender
There were 55 studies that reported the prevalence of dyspepsia according to the
gender of participants. Overall, the pooled prevalence of dyspepsia was slightly higher in
women compared with men (25.3% (95% CI 21.1% to 29.8%) versus 21.9% (95% CI 17.6%
to 26.5%)), and the OR for dyspepsia in women compared with men was 1.24 (95% CI 1.13
to 1.36), with significant heterogeneity between studies (I2 = 91.9%, P < 0.001), but no
evidence of funnel plot asymmetry (Egger test, P = 0.86). We studied the effect of
geographical region on prevalence according to gender. This demonstrated modestly
increased ORs among women in North American, North European, South European, Middle
Eastern, and South East Asian studies, but not African, South American, Australasian, or
Central American studies (Figure 4). When only the 21 studies that used a broad definition of
dyspepsia were included in the analysis, this difference was no longer statistically significant
(OR = 1.10; 95% CI 0.99 to 1.23, I2 = 89.2%, P < 0.001).
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Prevalence of Dyspepsia According to Smoking Status
There were 19 studies that reported the prevalence of dyspepsia according to smoking
status. The pooled prevalence of dyspepsia was higher in current smokers compared with
non-smokers (31.9% (95% CI 22.6% to 41.9%) versus 27.4% (95% CI 19.4% to 36.3%)).
The OR for dyspepsia in those who smoked currently compared with those who did not was
1.25 (95% CI 1.12 to 1.40), with significant heterogeneity between studies (I2 = 76.0%, P <
0.001), but no evidence of funnel plot asymmetry (Egger test, P = 0.21). There were nine
studies that used a broad definition of dyspepsia reporting effect of smoking status on
dyspepsia prevalence. When only these studies were included in the analysis there was still a
significantly higher prevalence of dyspepsia among smokers (OR = 1.35; 95% CI 1.17 to
1.56, I2 = 77.8%, P < 0.001).
Prevalence of Dyspepsia According to NSAID Use
There were 13 studies reporting the prevalence of dyspepsia according to NSAID use.
Overall, there were 1687 (36.5%) of 4622 NSAID users reporting dyspepsia, compared with
6180 (31.7%) of 19 483 non-users. When data from these studies were pooled, the prevalence
of dyspepsia was significantly higher among NSAID users (OR = 1.59; 95% CI 1.27 to 1.99),
with significant heterogeneity between studies (I2 = 88.3%, P < 0.001), but no evidence of
funnel plot asymmetry (Egger test, P = 0.14). When only the six studies that used a broad
definition of dyspepsia were included in the analysis, the difference remained statistically
significant (OR = 1.25; 95% CI 1.02 to 1.52, I2 = 75.3%, P = 0.001).
Prevalence of Dyspepsia According to H. pylori Status
There were 13 studies reporting the prevalence of dyspepsia according to H. pylori
status. All of these studies used a broad definition of dyspepsia. Overall, there were 3223
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(38.4%) of 8394 H. pylori-positive individuals reporting dyspepsia, compared with 5787
(34.2%) of 16 911 H. pylori-negatives. When data from these studies were pooled, the
prevalence of dyspepsia was significantly higher among H. pylori-positive individuals (OR =
1.18; 95% CI 1.04 to 1.33), with significant heterogeneity between studies (I2 = 63.0%, P <
0.001), but no evidence of funnel plot asymmetry (Egger test, P = 0.30).
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DISCUSSION
This systematic review and meta-analysis has assembled data from all available and
identified population-based cross-sectional surveys that report the prevalence of
uninvestigated dyspepsia in the community. It has demonstrated that prevalence varies
strikingly, from <2% to 57%, according to the geographical location of the population under
study. The criteria used also led to differences in prevalence, which was lowest when the
Rome III criteria were used, and highest with a broad definition of dyspepsia. However, the
variation in prevalence according to country persisted, even when the same diagnostic criteria
were used. In terms of symptom duration, prevalence was highest when symptoms were
present for a minimum of 1 month, although only four studies used this time interval, and
higher with studies that used a 6-month time frame compared with 12 months. Prevalence
remained remarkably similar according to the method of data collection, with the exception
of when a face-to-face interview was used, or an internet-based questionnaire. Finally,
prevalence of uninvestigated dyspepsia was significantly higher in females, smokers, NSAID
users, and H. pylori-positive individuals.
This study has several strengths. We used an exhaustive and contemporaneous search
strategy in order to maximise the likelihood of identifying all pertinent literature. The judging
of study eligibility and data extraction were carried out by two investigators independently,
with discrepancies resolved by consensus. We contacted primary or senior authors of studies
to ensure that duplicate publications from identical cohorts under extended follow-up were
not included and, in some cases, to obtain extra data. We also included data from eligible
foreign language articles, after translation, in order to be as inclusive as possible. We used a
random effects model to pool data in order to provide a more conservative estimate of the
prevalence of uninvestigated dyspepsia, and assessed for publication bias, where sufficient
studies existed. Finally, we limited studies to those based in the general population, and
Ford et al. 20 of 44
excluded those conducted among convenience samples, meaning that the likelihood that the
prevalence of uninvestigated dyspepsia has been inflated has been minimised, and the data
we report should therefore be generalisable to individuals in the community.
Limitations of this study include the variability in methods used to collect data. It may
be that more personal approaches to collecting data, such as a face-to-face or telephone
interview overestimate the prevalence of dyspepsia, while for more impersonal methods, such
as completion of a questionnaire over the internet, the converse is true. The paucity or
absence of studies reporting the prevalence of uninvestigated dyspepsia for some
geographical regions, such as Africa, Central America, and South Asia is another limitation.
In addition, there was significant heterogeneity between studies in all our analyses, which
was not explained by any of the subgroup analyses we conducted. The reasons for the
heterogeneity are therefore speculative, but may include subtle differences in the way
diagnostic criteria for dyspepsia were defined, or other demographic or cultural differences
between study populations, including ethnicity, which were not possible to examined using
the data that were available for extraction in the individual studies we identified. This
heterogeneity may be seen, by some, as precluding the pooling of data from these studies in a
meta-analysis. However, we feel that the summary data obtained using this approach are
useful in order to be able to view the prevalence of uninvestigated dyspepsia in the
community from an epidemiological and global perspective.
There have been few previous systematic reviews examining the prevalence of upper
GI symptoms in the community. The most recent of these was published 15 years ago, [127]
and also concentrated on true population prevalence surveys. Upper abdominal pain or
discomfort was reported by anywhere from 8% to over 50% of study subjects, which is
broadly similar to the prevalence we observed. However, this was performed by a single
author, so the methodology is unlikely to be as rigorous as that used in the present study, and
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no synthesis of data was conducted. In addition, there were no analyses performed to examine
potential risk factors for dyspepsia. Finally, there were only 10 included studies in this
systematic review, highlighting that a considerable amount of data has been published since it
was conducted, and emphasising the need for a contemporaneous study such as ours.
The findings of this study have implications for both future research and clinical
practice. Population-based studies using the Rome III criteria to define dyspepsia remain
scarce, despite the fact that these criteria were published 8 years ago, [3] although there have
been few validation studies of these criteria. [128] Extracting and analysing study data on the
prevalence of uninvestigated dyspepsia has emphasised the magnitude of this disorder within
the community, and thus the implications for health services worldwide, including those in
some of the poorest nations in the world. A recent questionnaire survey reported that the
mean yearly cost of dyspepsia to patients was almost $700, [16] and burden of illness studies
in the USA estimated that there were almost 2 million physician visits in 2009 as a result of
dyspepsia, [129] and >30% of endoscopies were performed with dyspepsia as the main
indication. [130] However, the prevalence of uninvestigated dyspepsia in some geographical
regions, such as Africa, South Asia, and Central America needs further study. These data can
also be used for ecological studies to evaluate risk factors for dyspepsia. For example, some
investigators have shown that duodenal eosinophilia is associated with dyspepsia. [131, 132]
This suggests that there is either an infective or an allergic component to dyspepsia and, in
order to investigate this, our data could be plotted against the prevalence of asthma at a
country level.
In terms of future treatment trials in uninvestigated dyspepsia, as well as
epidemiological studies of the condition, our meta-analysis suggests that the methods used to
collect symptom data, as well as the symptom duration used to define its presence, may affect
the prevalence of dyspepsia when identifying and recruiting suitable subjects, as well as the
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response of symptoms to therapy. In addition, the modest contribution of most of the risk
factors that were reported in the studies we identified to the odds of reporting symptoms
implies that either other factors need to be examined to identify those most at risk of
dyspepsia in the community, or alternatively the cumulative effect of each of these risk
factors, or the interaction between them, needs to be examined using more complex statistical
methods.
In conclusion, this systematic review and meta-analysis has demonstrated a global
prevalence of uninvestigated dyspepsia of almost 21%, but this varied, considerably in some
instances, according to geographical region, diagnostic criteria used to define dyspepsia, and
minimum symptom duration required. The striking variation in prevalence throughout the
world, even when the same diagnostic criteria are used to define dyspepsia, highlights the
importance of other factors such as genetic, ethnic, and cultural differences on the reporting
of upper GI symptoms. Risk factors for uninvestigated dyspepsia included female gender,
smoking, NSAID use, and H. pylori infection. However, these associations were modest,
their overall importance in the aetiology of symptoms is questionable, and there are clearly
other factors that are involved in the pathogenesis of dyspepsia that we were unable to
elucidate via analysis of data from the studies we identified.
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Box 1: Eligibility Criteria
Cross-sectional surveys
5HFUXLWHGDGXOWV!RISDUWLFLSDQWVDJHG\HDUV
Participants recruited from the general population / community*
Reported prevalence of dyspepsia (according to a questionnaire, or specific diagnostic
criteria†)
6DPSOHVL]HRISDUWLFLSDQWV     
*Convenience samples excluded
†Broad definition of dyspepsia including any symptom referable to the upper GI tract, upper
abdominal or epigastric pain or discomfort alone, Rome I, II, or III criteria
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FIGURES
Figure 1. Prevalence of Uninvestigated Dyspepsia Worldwide Using a Broad Definition.
Figure 2. Prevalence of Uninvestigated Dyspepsia Worldwide Using Upper Abdominal
or Epigastric Pain or Discomfort.
Figure 3. Prevalence of Uninvestigated Dyspepsia Worldwide Using the Rome II
Criteria.
Figure 4. Odds ratio for Uninvestigated Dyspepsia in Women Versus Men According to
Geographical Location.
